Stay updated on AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial
Sign up to get notified when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.

Latest updates to the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 appears on the page, replacing the previous v3.3.3. This looks like a site version update with no impact on the study details.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section added: Connecticut, Massachusetts, New York, and Tennessee; HHS Vulnerability Disclosure link removed.SummaryDifference0.4%

- Check55 days agoChange DetectedPublication section text updated to reflect PubMed auto-fill and a new revision stamp v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding outage notice has been removed from the page, and the study details remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedNo additions or deletions were detected in the page content. The study details, eligibility criteria, and locations remain the same.SummaryDifference0.4%

- Check97 days agoChange DetectedRemoved study-level clinical trial data sections (Information, Comments, Results synopsis).SummaryDifference0.2%

Stay in the know with updates to AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.